Excelsior Biopharma Inc. 6496.TWO
6496.TWO
Excelsior Biopharma Inc. 6677.TWO
Anxo Pharmaceutical Co., Ltd. 6645.TW
Kim Forest Enterprise Co., Ltd. 6539.TWO
DV Biomed Co., Ltd. 6935.TWO
Prince Pharmaceutical Co., Ltd. 6810.TWO
Bio Preventive Medicine Corp. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 4150.TWO
Unicon Optical Co., Ltd. 4194.TWO
Holy Stone Healthcare Co., Ltd. 6872.TWO
NaviFUS Corp.
Excelsior Biopharma Inc. 6677.TWO
Anxo Pharmaceutical Co., Ltd. 6645.TW
Kim Forest Enterprise Co., Ltd. 6539.TWO
DV Biomed Co., Ltd. 6935.TWO
Prince Pharmaceutical Co., Ltd. 6810.TWO
Bio Preventive Medicine Corp. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 4150.TWO
Unicon Optical Co., Ltd. 4194.TWO
Holy Stone Healthcare Co., Ltd. 6872.TWO
NaviFUS Corp.
Performance
| Periode | 6496.TWO | 6677.TWO | 6645.TW | 6539.TWO | 6935.TWO | 6810.TWO | 7427.TWO | 4150.TWO | 4194.TWO | 6872.TWO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 9.81 % | 39.18 % | 8.97 % | -7.41 % | 50.58 % | 0.00 % | -13.40 % | 9.27 % | 30.81 % | -13.21 % |
| YTD | -3.32 % | 5.39 % | 0.00 % | 3.37 % | 42.01 % | -20.67 % | -6.71 % | -34.84 % | -23.00 % | -25.54 % |
| 1Y | -3.32 % | -22.44 % | -5.20 % | -3.24 % | 40.78 % | -22.73 % | -17.21 % | -34.60 % | -39.81 % | -29.35 % |
| 3Y | 8.58 % | 34.39 % | -9.40 % | -85.08 % | -37.60 % | -27.59 % | 4.95 % | 14.87 % | -51.82 % | -2.68 % |
| 5Y | -1.19 % | -4.33 % | -50.29 % | -88.86 % | -37.60 % | 14.92 % | -43.68 % | -42.89 % | -26.68 % | -14.92 % |
| 10Y | -51.09 % | -45.16 % | 31.81 % | -89.28 % | -37.60 % | 14.92 % | -43.68 % | -71.12 % | -67.86 % | -14.92 % |
| From the beginning | -61.20 % | -45.16 % | 31.81 % | -90.06 % | -37.60 % | 14.92 % | -43.68 % | -89.76 % | -90.73 % | -14.92 % |